Fatty acid 2-hydroxylase
| GO Term | Evidence Code | Reference |
|---|---|---|
| sebaceous gland cell differentiation |
|
|
| fatty acid metabolic process | ||
| fatty acid biosynthetic process |
|
|
| glucosylceramide biosynthetic process | ||
| glucosylceramide biosynthetic process |
| GO Term | Evidence Code | Reference |
|---|---|---|
| endoplasmic reticulum | ||
| endoplasmic reticulum membrane | ||
| endoplasmic reticulum membrane | ||
| membrane | ||
| membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| iron ion binding |
|
|
| heme binding | ||
| fatty acid 2-hydroxylase activity | ||
| fatty acid 2-hydroxylase activity | ||
| fatty acid 2-hydroxylase activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 158 |
|
| Pathway Name | Organism |
|---|---|
| Sphingolipid de novo biosynthesis | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0110786 | hereditary spastic paraplegia 35 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026